Technologies Empowering Drug Discovery and Development

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across new approaches fueling therapeutic advancements. The service encompasses a drug target discovery method, novel screening assays and innovative preclinical validation and testing platforms. Additionally, this TOE encompasses advances in treatment of pulmonary embolism, systemic sclerosis, as well as new drug repurposing methods and trends.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Cell migration, invasion assay, drug target discovery, deubiquitylases screening, preclinical validation, preclinical testing, multi-organ chip, nanotechnology, pulmonary embolism, systemic sclerosis, cannabinoid, drug repositioning, phenotypic screening, drug repurposing, drug discovery

Table of Contents

Technologies Empowering Drug Discovery and DevelopmentRecent Innovations for Development of Therapeutics Multiparametric Cell Migration and Invasion Assays for Target Drug DiscoverySmart Deubiquitylases Screening AssaysState-of-the-art Digital Vivarium Enhancing Preclinical ValidationMulti-organ Chip Platform Addressing Preclinical Testing Using Nanotechnology for Treatment of Pulmonary EmbolismCannabinoid-based Drug for Systemic Sclerosis Drug Repositioning Through Phenotypic ScreeningDrug DiscoveryTechnology Focus and TrendsTechnology Focus and TrendsThree Start Ups Companies to WatchIndustry Interactions




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.